MX2020003665A - Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende por lo menos un aditivo. - Google Patents
Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende por lo menos un aditivo.Info
- Publication number
- MX2020003665A MX2020003665A MX2020003665A MX2020003665A MX2020003665A MX 2020003665 A MX2020003665 A MX 2020003665A MX 2020003665 A MX2020003665 A MX 2020003665A MX 2020003665 A MX2020003665 A MX 2020003665A MX 2020003665 A MX2020003665 A MX 2020003665A
- Authority
- MX
- Mexico
- Prior art keywords
- transdermal
- guanfacine
- therapeutic system
- additive
- transdermal therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a un sistema terapéutico transdérmico para la administración transdérmica de guanfacina que comprende una estructura de capa que contiene guanfacina, dicha estructura de capa comprende: A) una capa de refuerzo; y B) una capa que contiene guanfacina; en donde el sistema terapéutico transdérmico comprende al menos un polímero y al menos un aditivo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762570745P | 2017-10-11 | 2017-10-11 | |
EP17205546 | 2017-12-05 | ||
PCT/EP2018/077792 WO2019072998A1 (en) | 2017-10-11 | 2018-10-11 | TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL DELIVERY OF GUANFACIN HAVING AT LEAST ONE ADDITIVE |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020003665A true MX2020003665A (es) | 2020-10-01 |
Family
ID=63878660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020003665A MX2020003665A (es) | 2017-10-11 | 2018-10-11 | Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende por lo menos un aditivo. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20200397715A1 (es) |
EP (1) | EP3694498A1 (es) |
JP (1) | JP7445218B2 (es) |
KR (1) | KR20200070306A (es) |
CN (1) | CN111447926B (es) |
AU (1) | AU2018348802A1 (es) |
BR (1) | BR112020007011A2 (es) |
CA (1) | CA3079697A1 (es) |
MX (1) | MX2020003665A (es) |
TW (1) | TWI829654B (es) |
WO (1) | WO2019072998A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3079696A1 (en) | 2017-10-11 | 2019-04-18 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone polymer |
EP4395749A1 (en) * | 2021-08-30 | 2024-07-10 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system for the transdermal administration of guanfacine comprising guanfacine and a mono-carboxylic acid |
WO2024040897A1 (zh) * | 2022-08-24 | 2024-02-29 | 新领医药技术(深圳)有限公司 | 沙利度胺或其类似物透皮贴剂及其制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62289514A (ja) * | 1986-04-03 | 1987-12-16 | ハ−コン ラボラトリ−ズ コ−ポレ−シヨン | 薬理活性物質を経皮、経口又は皮下移植により投与する為の製品 |
JPH01265021A (ja) * | 1987-10-29 | 1989-10-23 | Hercon Lab Corp | 薬理学的活性物質を含有する組成物を動物組織に制御放出および供給するための物品 |
US5028431A (en) * | 1987-10-29 | 1991-07-02 | Hercon Laboratories Corporation | Article for the delivery to animal tissue of a pharmacologically active agent |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5762952A (en) * | 1993-04-27 | 1998-06-09 | Hercon Laboratories Corporation | Transdermal delivery of active drugs |
JPH07145048A (ja) * | 1993-11-25 | 1995-06-06 | Sekisui Chem Co Ltd | 医療用貼付剤 |
DE69922257T2 (de) * | 1998-07-29 | 2005-11-10 | Teijin Ltd. | Druckempfindliche klebstoffzusammensetzung und feuchtigkeitsdurchlässiges, druckempfindliches klebeband, druckempfindliche, pharmazeutische klebstoffzusammensetzung und herstellung eines druckempfindlichen klebebandes welches diese zusammensetzung enthält |
CN100411692C (zh) * | 2004-01-13 | 2008-08-20 | 北京康倍得医药技术开发有限公司 | 丙烯酸基粘合剂组合物及其药物组合物和透皮治疗系统 |
KR101432698B1 (ko) | 2006-06-06 | 2014-08-22 | 다우 코닝 코포레이션 | 실리콘 아크릴레이트 하이브리드 조성물 |
BRPI1014886B1 (pt) | 2009-04-24 | 2020-02-11 | Henkel IP & Holding GmbH | Polímeros acrílicos de silicone híbridos, seus métodos de preparação, adesivos e soluções de uma composição adesiva sensível à pressão compreendendo os mesmos. |
JP2013139554A (ja) | 2011-11-29 | 2013-07-18 | Dow Corning Corp | シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法 |
CA2896055C (en) * | 2012-12-28 | 2021-02-16 | Noven Pharmaceuticals, Inc. | Compositions and methods for transdermal delivery of amphetamine and clonidine |
WO2016130408A1 (en) | 2015-02-09 | 2016-08-18 | Dow Corning Corporation | Multi-phase silicone acrylic hybrid visco-elastic compositions and methods of making same |
EP3349737A4 (en) * | 2015-09-14 | 2019-05-15 | Amneal Pharmaceuticals LLC | SYSTEM FOR TRANSDERING |
-
2018
- 2018-10-11 CA CA3079697A patent/CA3079697A1/en active Pending
- 2018-10-11 MX MX2020003665A patent/MX2020003665A/es unknown
- 2018-10-11 EP EP18788719.5A patent/EP3694498A1/en active Pending
- 2018-10-11 US US16/755,049 patent/US20200397715A1/en active Pending
- 2018-10-11 AU AU2018348802A patent/AU2018348802A1/en active Pending
- 2018-10-11 BR BR112020007011-4A patent/BR112020007011A2/pt unknown
- 2018-10-11 WO PCT/EP2018/077792 patent/WO2019072998A1/en unknown
- 2018-10-11 TW TW107135749A patent/TWI829654B/zh active
- 2018-10-11 KR KR1020207013347A patent/KR20200070306A/ko not_active Application Discontinuation
- 2018-10-11 CN CN201880066613.1A patent/CN111447926B/zh active Active
- 2018-10-11 JP JP2020519801A patent/JP7445218B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
EP3694498A1 (en) | 2020-08-19 |
JP2020536882A (ja) | 2020-12-17 |
CN111447926B (zh) | 2024-04-30 |
AU2018348802A1 (en) | 2020-04-16 |
JP7445218B2 (ja) | 2024-03-07 |
US20200397715A1 (en) | 2020-12-24 |
BR112020007011A2 (pt) | 2020-10-06 |
TW201927295A (zh) | 2019-07-16 |
KR20200070306A (ko) | 2020-06-17 |
RU2020115562A3 (es) | 2022-02-10 |
CN111447926A (zh) | 2020-07-24 |
RU2020115562A (ru) | 2021-11-15 |
TWI829654B (zh) | 2024-01-21 |
WO2019072998A1 (en) | 2019-04-18 |
CA3079697A1 (en) | 2019-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018001134A1 (es) | Composiciones y métodos para inhibir la actividad arginasa | |
CL2022001189A1 (es) | Anticuerpos para cd40. (divisional de solicitud n° 2017003427) | |
BR112016012615A8 (pt) | sistemas, e kit | |
CL2018000299A1 (es) | Composiciones con potenciadores de impregnacion para el suministro de fármacos. | |
ECSP19021223A (es) | Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo | |
CL2015003314A1 (es) | Inhibidores de acc y usos de los mismos | |
CL2018002532A1 (es) | Composición farmacéutica que comprende empagliflozina y sus usos | |
CL2015002164A1 (es) | Formulación combinada de dos compuesos antivirales. | |
CL2016000009A1 (es) | Tratamiento de rosacea papulopustular con ivermectina. | |
CR20160289A (es) | Compuestos de inhibidor de autotaxina | |
CL2014001994A1 (es) | Polipeptido mimético de apelina sintéticos para el tratamiento e insuficiencia cardiaca; composicion farmacéutica que comprende dicho polipeptido. | |
BR112016018455A2 (pt) | composto, ácido, medicamento, métodos para prevenir ou tratar obesidade e diabetes melito e para inibir uma enteropeptidase, e, uso de um composto. | |
CO6571889A2 (es) | Antidotos anticoagulantes | |
CO2017005500A2 (es) | Método para la producción de un sistema de administración farmacéutica | |
GT201400012A (es) | Compuesto inhibidor de la señalizacion de la trayectoria notch | |
BR112018008103A2 (pt) | análogos de celastrol | |
ECSP17044282A (es) | Formulación de relación fija de insulina glargina/lixisenatida | |
BR112017005361A2 (pt) | emplastro de opipramol | |
MX2020003665A (es) | Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende por lo menos un aditivo. | |
CL2015002253A1 (es) | Composiciones farmacéuticas para el tratamiento de la helicobacter pylori. | |
AR094289A1 (es) | Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol | |
MX2020003667A (es) | Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero de silicona. | |
EA201400628A1 (ru) | Трансдермальная терапевтическая система для введения фентанила или его аналога | |
PE20150721A1 (es) | Composicion farmaceutica que comprende gemigliptina y metformina, y metodo para su preparacion | |
UY36217A (es) | Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso. |